The adaptogenic action of AnnonaSense CLR supports the endocannabinoid system (ECS) by activating the CB2 receptor. Inflammatory processes induced by the TRPV1 receptor, part of the skin’s endovanilloid system (EVS), are strongly down regulated and a stable balance between the ECS and EVS is established.
AnnonaSense CLR makes the skin less sensitive and more balanced, so that even itch could perceivably be reduced. Skin appearance becomes clearly better and a consumer study showed that perception of well-being and quality of life were improved. AnnonaSense CLR is obtained from Annona cherimola, common name Cherimoya, an edible fruit originating from South America.
More info: www.clr-berlin.com